Total Visits

Views
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction308

File Visits

Downloads
ijms-24-02536-v2-1.pdf62

Select a period of time:

ViewsDownloads

Number of views in the range

Views
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction158

Number of downloads in the range

Downloads
ijms-24-02536-v2-1.pdf29

Views

Views
April 202541
May 202539
June 202529
July 20254
August 202517
September 202523
October 20255
Download CSV file
 
Bar graph
 
Line graph

Number of downloads in the period of time

  • Downloads
  • April 2025
    3
  • May 2025
    3
  • June 2025
    1
  • July 2025
    3
  • August 2025
    6
  • September 2025
    8
  • October 2025
    5
 
Bar graph
 
Line graph

Top country views

Views
United States61
Brazil20
Spain14
Russia9
Vietnam9
Hong Kong9
China6
Ukraine4
Germany3
Singapore3

Top countries by downloads

Downloads
United States12
Hong Kong5
Spain3
Singapore3
Russia2

Top cities views

Views
Central9
Inca8
Valladolid5
Ho Chi Minh City4
Kyiv3
Singapore3
Chicago3
Belo Horizonte2
Frankfurt am Main2
Hanoi2

Top cities by downloads

Downloads
Central4
Singapore3
Inca2
Chicago1